Statistics for Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
Total visits
| views | |
|---|---|
| Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial | 62 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| Burns2021Infliximab-CCBYNCND.pdf | 37 |
Top country views
| views | |
|---|---|
| United States | 51 |
| France | 2 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Ann Arbor | 3 |
| Mount Laurel | 2 |
| Paris | 2 |
| Cambridge | 1 |
| Seremban | 1 |
| Washington | 1 |